Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
October 08 2024 - 5:44PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
|
|
SCHEDULE 13G |
(Rule 13d-102) |
|
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT |
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED |
PURSUANT TO RULE 13d-2 |
(Amendment No. 1) * |
|
|
Foghorn Therapeutics Inc. |
(Name of Issuer) |
|
|
Common Stock, $0.0001 par value |
(Title of Class of Securities) |
|
344174107 |
(CUSIP Number) |
|
|
September 30, 2024 |
(Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise
subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
1. |
NAME OF REPORTING PERSON
The Klarman Family Foundation |
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ] |
3. |
SEC USE ONLY |
4. |
CITIZENSHIP OR PLACE OF ORGANIZATION
Massachusetts |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE VOTING POWER
0 |
6. |
SHARED VOTING POWER
2,139,639 |
7. |
SOLE DISPOSITIVE POWER
0 |
8. |
SHARED DISPOSITIVE POWER
2,139,639 |
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON
2,139,639 |
10. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW
(9) EXCLUDES [_]
CERTAIN SHARES |
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.9% (1) |
12. |
TYPE OF REPORTING PERSON
OO |
|
|
|
|
(1) Based on 55,328,655 shares of Common Stock outstanding as of
July 31, 2024, as reported in the Issuer’s Report on Form 10-Q for the period ended June 30, 2024 filed with the Securities and
Exchange Commission on August 8, 2024.
1. |
NAME OF REPORTING PERSON
Seth A. Klarman |
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ] |
3. |
SEC USE ONLY |
4. |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE VOTING POWER
0 |
6. |
SHARED VOTING POWER
2,139,639 (1) |
7. |
SOLE DISPOSITIVE POWER
0 |
8. |
SHARED DISPOSITIVE POWER
2,139,639 (1) |
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY REPORTING PERSON
2,139,639 (1) |
10. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW
(9) EXCLUDES [_]
CERTAIN SHARES |
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.9% (2) |
12. |
TYPE OF REPORTING PERSON
IN, HC |
|
|
|
|
(1) Represents shares held by The
Klarman Family Foundation. Mr. Klarman may be deemed to share
beneficial ownership of such shares within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, however he has no pecuniary
interest therein.
(2) Based on 55,328,655 shares of Common Stock outstanding as of
July 31, 2024, as reported in the Issuer’s Report on Form 10-Q for the period ended June 30, 2024 filed with the Securities and
Exchange Commission on August 8, 2024.
AMENDMENT NO. 1 TO SCHEDULE 13G (FINAL AMENDMENT)
Reference is hereby made to the statement on Schedule 13G filed with the
Securities and Exchange Commission by the Reporting Persons with respect to the Common Stock of the Issuer on February 4, 2021 (the “Schedule
13G”). Terms defined in the Schedule 13G are used herein as so defined.
The following Items of the Schedule 13G are hereby amended and restated
as follows:
Item 4. Ownership
(a) through (c):
The information requested in these paragraphs is incorporated by reference
to the cover pages to this Amendment No. 1 to Schedule 13G.
Item 5. Ownership of Five Percent or Less of the
Class
If this statement is being filed to report the fact that the Reporting
Persons have ceased to be the beneficial owners of more than five percent of the Common Stock, check the following: [X]
SIGNATURES
After reasonable inquiry and to the best of the knowledge and belief of
the undersigned, the undersigned certify that the information set forth in this Statement is true, complete and correct.
Dated: October 8, 2024
THE KLARMAN FAMILY FOUNDATION
By: KFO, LLC, its investment manager
By: _/s/ David P. Berkowitz______
Name: David P. Berkowitz
Title: Chief Investment Officer
SETH A. KLARMAN
_/s/ Seth A. Klarman___________
Seth A. Klarman, individually
Foghorn Therapeutics (NASDAQ:FHTX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Foghorn Therapeutics (NASDAQ:FHTX)
Historical Stock Chart
From Nov 2023 to Nov 2024